Data as of .
FMED vs XT: which is really different?
FMED and XT hold 3% of their weight in the same names, and FMED returned more over the year.
ETFIQ Off-Index Score: FMED scores higher
How much of it is not the index it is sold as an alternative to?
A percentile among the 379 thematic ETFs with a holdings filing. It is a position in a set, not a rating, and neither end of it is a recommendation. All thematic ETFs ranked by it · How it is computed
3% of the two portfolios are the same securities at the same weight.
What they hold in common
By the books each fund has filed, FMED and XT hold 3% of their money in the same securities at the same weight.
| Only in FMED | Only in XT |
|---|---|
| UCB SA 4.75% | TESLA INC 4.10% |
| LIFESTANCE HEALTH GROUP INC 4.29% | TEXAS INSTRUMENT INC 4.06% |
| DANAHER CORP 3.43% | ELI LILLY 4.00% |
| 10X GENOMICS INC 3.12% | MICROSOFT 3.94% |
| INTUITIVE SURGICAL INC 2.93% | NVIDIA 3.85% |
| COGENT BIOSCIENCES INC 2.86% | PALO ALTO NETWORKS 3.43% |
| ALNYLAM PHARMACEUTICALS INC 2.80% | JOHNSON & JOHNSON 3.13% |
| ARGENX SE 2.79% | ANALOG DEVICES 3.03% |
Weight overlap is an ETFIQ calculation: for every security both funds hold, the smaller of the two weights, summed. Above 50%, holding both is close to holding one of them twice. Holdings dated May 31, 2026 and Sep 18, 2026.
Performance, window by window
| Window | Total return | vs the S&P 500 | vs the Nasdaq-100 | |||
|---|---|---|---|---|---|---|
| FMED | XT | FMED | XT | FMED | XT | |
| 3 months | +21.3% | 0.0% | +19.0 pts | −2.3 pts | +23.7 pts | +2.5 pts |
| 6 months | +32.3% | +22.9% | +14.3 pts | +4.8 pts | +8.0 pts | −1.4 pts |
| 1 year | +28.3% | +24.4% | +11.7 pts | +7.8 pts | +6.5 pts | +2.6 pts |
| 3 years | +39.6% | +67.9% | −38.8 pts | −10.5 pts | −58.5 pts | −30.2 pts |
| Since launch | +25.8% | +284.5% | −57.6 pts | −56.6 pts | −78.1 pts | −342.6 pts |
| FMED Fidelity Disruptive Medicine ETF Holds 68 stocks in broad innovation and megatrends, 25% of its weight in S&P 500 companies | XT iShares Future Exponential Technologies ETF Holds 225 stocks in broad innovation and megatrends, 64% of its weight in S&P 500 companies | |
|---|---|---|
| Issuer | Fidelity | iShares |
| Theme | Broad innovation and megatrends | Broad innovation and megatrends |
| In the S&P 500 | 25.4% | 64.5% |
| Active share vs the S&P 500 | 97.1% | 67.5% |
| In the Nasdaq-100 | 8.7% | 39.4% |
| Holdings | 68 | 225 |
| Top ten, share of the fund | 31.5% | 33.9% |
| Expense ratio | 0.50% | 0.46% |
| Fee for the differing part | 0.51% | 0.68% |
| Total return, 1 year | +28.3% | +24.4% |
| vs the S&P 500 | +11.7 pts | +7.8 pts |
| vs the Nasdaq-100 | +6.5 pts | +2.6 pts |
| Below its high | −3.8% | −1.9% |
| Net assets | $52m | $4.0bn |
FMED in plain words
By weight, 25% of FMED's portfolio is stocks that are also in the S&P 500; its active share against the S&P 500 is 97%. The top ten holdings are 32% of the fund across 68 positions, as filed for May 31, 2026. Over the year to Sep 18, 2026 the fund returned +28.3% with distributions reinvested against +16.6% for the S&P 500, so a holder was ahead by 11.7 pts.
XT in plain words
By weight, 64% of XT's portfolio is stocks that are also in the S&P 500; its active share against the S&P 500 is 68%. The top ten holdings are 34% of the fund across 225 positions, as published by its issuer for Sep 18, 2026. Over the year to Sep 18, 2026 the fund returned +24.4% with distributions reinvested against +16.6% for the S&P 500, so a holder was ahead by 7.8 pts.
Questions people ask
- Do FMED and XT hold the same stocks?
- By their latest filings, 3% of their books are the same securities at the same weight, which is mostly different names. Overlap is the sum of the smaller weight of every security they share.
- Which is more different from the S&P 500, FMED or XT?
- FMED has 25% of its weight in S&P 500 names and XT has 64%, so FMED differs more from the index.
- Which is cheaper, FMED or XT?
- FMED charges 0.50% a year and XT charges 0.46%, so XT is cheaper. Fees come from each fund's prospectus.
Other comparisons
Where these figures came from
ETFIQ links to the documents behind every figure. It is not affiliated with any issuer, and a link is not an endorsement.
Cite this page. ETFIQ, FMED against XT, data as of Sep 18, 2026. https://etfiq.com/compare/themes/fmed-vs-xt Free to use with attribution; the underlying files are at Open data.